New Delhi [India], November 28: CliniExperts Research Services Pvt. Ltd., New Delhi, India proudly announces the successful completion of Phase IV study on Akynzeo® I.V for Glenmark Pharmaceuticals ltd. As a CRO, CliniExperts provided end to end Clinical Support including Site Management and
Chief Minister of Goa, Dr. Pramod Sawant, laid the foundation stone for the Indian Oil Corporation Limited (IOCL) Fuel Pump at Colvale and Sada Sub Jail. He also inaugurated the Sewerage Treatment Plant, Paper Waste Recycling Project and Water Conservation Project at Central Jail Colvale und
Mumbai (Maharashtra) [India], May 21: Glenmark Specialty S.A. (Glenmark), a subsidiary of Glenmark Pharmaceuticals Ltd., a research-led, global pharmaceutical company, today announced an exclusive marketing and distribution agreement with BeiGene, a global oncology company. Under this agreem
A trainee of the Khelo India Glenmark Centre in New Delhi, Bhumi won the gold in the 200m Individual Medley with a time of 2 minutes 32.43 seconds and then returned to bag a bronze in 100m freestyle and a silver in the 4x100m freestyle relay
Mumbai (Maharashtra) [India], February 15: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical Company, today announced its financial results for the third quarter ended December 31, 2023.
Mumbai (Maharashtra) [India], January 31: Glenmark Pharmaceuticals Ltd. (Glenmark), a leading, research-driven, global pharmaceutical company, and Ichnos Sciences Inc. (Ichnos), its global fully integrated, clinical-stage biotech subsidiary, today announced the launch of their alliance - Ich
Mumbai (Maharashtra) [India], January 3: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular 10,11 anti-diabetic drug, Liraglutide, for the first time in India. The drug is being marketed under the brand name Liraf
Mumbai (Maharashtra) [India], December 4: Candid Dusting Powder, the flagship product by Glenmark Pharmaceuticals and a market leader in the Over The Counter (OTC) anti-fungal powder category, has concluded a series of impactful festive brand activations, showcasing an unwavering commitment
Mumbai (Maharashtra) [India], November 11: Glenmark Pharmaceuticals Ltd. (Glenmark), a research led, global pharmaceutical company, today announced its financial results for the second quarter ended Sept 30, 2023.
Mahwah (New Jersey) [US]/ Mumbai (Maharashtra) [India], November 7: Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg, the generic versi
Mumbai (Maharashtra) [India]/ Dublin [Ireland], September 27: Cosmo Pharmaceuticals N.V. (SIX: COPN) (XETRA: C43) ('Cosmo') and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. ('Glenmark'), today announced the signing of distribution and license agreements for Winlevi&
Mumbai (Maharashtra) [India], September 22: In a successful bid, Nirma Group has entered into definitive agreement to acquire 75 per cent of Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited at an enterprise value of about Rs 7,500 Crore, subject to closing adjustments. Ni